1. Is Neonatal Hyperbilirubinemia Exposure Associated with a Risk of Autism Spectrum Disorder? A Nationwide Cohort Study
- Author
-
Hui-Hsien Pan, Pen-Fen Liao, Hsuan-Ju Chen, Tung-Wei Hung, Jeng-Dau Tsai, and Ji-Nan Sheu
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Autism Spectrum Disorder ,Exchange Transfusion, Whole Blood ,Infant, Newborn, Diseases ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,mental disorders ,Humans ,Medicine ,Risk factor ,Proportional Hazards Models ,Retrospective Studies ,030219 obstetrics & reproductive medicine ,business.industry ,Confounding ,Infant, Newborn ,Obstetrics and Gynecology ,Retrospective cohort study ,Infant, Low Birth Weight ,Phototherapy ,medicine.disease ,Confidence interval ,Low birth weight ,Autism spectrum disorder ,Pediatrics, Perinatology and Child Health ,Cohort ,Female ,Hyperbilirubinemia, Neonatal ,medicine.symptom ,business ,Infant, Premature ,Cohort study - Abstract
Objective This study aimed to determine whether neonatal hyperbilirubinemia is associated with a risk of autism spectrum disorder (ASD) using a large population-based cohort.Study Design This retrospective cohort study used data from the children's database (2000–2012) of the National Health Insurance Research Database (1996–2012) in Taiwan. We included neonates who were born between 2000 and 2004 and aged Results A total of 67,017 neonates were included. The neonates with hyperbilirubinemia were associated with 1.28-fold increased risk of ASD (HR = 1.28, 95% confidence interval [CI]: 1.05–1.57) compared with those without hyperbilirubinemia. In subanalysis to determine how phototherapy and exchange transfusion treatment for hyperbilirubinemia were associated with ASD showed no association between treatment and ASD, suggesting the lack of a dose-response effect of hyperbilirubinemia on the risk of ASD. Boys had a nearly six-fold higher risk of ASD than girls (HR = 5.89, 95% CI: 4.41–7.86). Additionally, neonates born with preterm birth and low birth weight were associated with a risk of ASD (HR = 1.46, 95% CI: 1.00–2.13).Conclusion We did not observe a dose-response effect of hyperbilirubinemia on ASD, but neonatal hyperbilirubinemia may be an independent risk factor for ASD if there is a residual confounding by other perinatal complications. Therefore, this study does not support a causal link between neonatal hyperbilirubinemia exposure and the risk of ASD.
- Published
- 2020
- Full Text
- View/download PDF